What are the proliferative breast diseases with no cellular atypia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Proliferative diseases of the breast without atypia include usual ductal hyperplasia, sclerosing adenosis, complex fibroadenomas, radial scars/complex sclerosing lesions, papillomas, and papillomatosis. These conditions are characterized by an overgrowth of normal-appearing cells within the breast ducts or lobules without cellular abnormalities that would suggest pre-cancerous changes 1. The key features of these diseases are:

  • Usual ductal hyperplasia: an increase in the number of cells lining the ducts
  • Sclerosing adenosis: a condition where the breast tissue becomes distorted and scarred
  • Complex fibroadenomas: benign tumors that contain a mixture of glandular and fibrous tissue
  • Radial scars/complex sclerosing lesions: areas of scar tissue that can mimic cancer on imaging studies
  • Papillomas: benign growths that occur in the ducts of the breast
  • Papillomatosis: a condition where there are multiple papillomas in the breast

These conditions are often discovered incidentally during breast biopsies performed for other reasons, and management typically involves regular breast cancer screening according to age-appropriate guidelines rather than surgical excision in most cases 1. It's essential to distinguish between proliferative diseases without atypia and those with atypia, such as atypical ductal hyperplasia, as the latter carry a significantly higher breast cancer risk 1. Understanding these benign proliferative conditions helps clinicians provide appropriate counseling and avoid unnecessary interventions while ensuring adequate surveillance.

From the Research

Proliferative Diseases with No Atypia of the Breast

The following are proliferative diseases with no atypia of the breast:

  • Usual ductal hyperplasia (UDH) 2
  • Adenosis 2
  • Sclerosing adenosis (SA) 2
  • Fibro cystic disease 2
  • Mucocele-like lesion (MLL) without atypia 2
  • Radial scar (RS) without atypia 2
  • Flat epithelial atypia (FEA) without atypia is not typically considered a proliferative disease with no atypia, as it is often associated with an increased risk of breast cancer 3
  • Proliferative disease without atypia, which has been shown to have an approximately 1.5x increased risk of subsequent breast cancer 4

Key Characteristics

These diseases are characterized by:

  • An increased risk of breast cancer, although the risk is generally lower than for atypical hyperplasia (AH) 4
  • A variety of mammographic appearances, including clustered microcalcifications 5
  • A need for careful clinical and radiologic follow-up to monitor for any changes or development of breast cancer 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Benign proliferative breast disease with and without atypia].

Journal de gynecologie, obstetrique et biologie de la reproduction, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.